Search

everythinglearnresearchcommunity

for

Search:↓

Over 60% of Korean military personnel had skin diseases, commonly acne and athlete's foot, linked to service length and stress.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The woman's skin condition persisted for 20 years despite treatments.

AI can predict hair loss patterns to improve care and treatment.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Hair count is important to distinguish between genetic hair thinning (Androgenetic Alopecia) and hair thinning caused by disrupted hair growth (Chronic Telogen Effluvium).

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

An arthritis drug helped a person with severe hair loss regrow their hair.

Iron deficiency is common in female military personnel but doesn't significantly impact daily physical activity.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Mouse models help understand alopecia areata and find treatments.

Surgical excision is an effective treatment for persistent nodules from poly-L-lactic acid injections.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Older men and those with outdoor jobs are at higher risk for skin cancer; early full-body skin checks are recommended for early detection.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Male pattern baldness may increase COVID-19 severity risk.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Patients need better information about the risks of long-term steroid use.

C3G and Vitisin A may help prevent hair loss by blocking male hormones and stopping hair cell death.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

The study identified key genes and pathways linked to hair disorders, aiding precision medicine.

The 7-month-old boy has a persistent rash that doesn't improve with typical skin treatments.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.